Risk Factors of Treatment-Limiting Anemia after Substitution of Zidovudine for Stavudine in HIV-Infected Adult Patients on Antiretroviral Treatment

BACKGROUND: Anemia is the main concern among patients using a zidovudine (AZT)-based antiretroviral treatment (ART). Some studies suggested weight-adjusted AZT dosing as a way to reduce toxicity. We analyzed the risk factors associated with AZT-induced anemia in a cohort using AZT as substitution fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Phe, Thong, Thai, Sopheak, Veng, Chhunheng, Sok, Sopheak, Lynen, Lutgarde, van Griensven, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608603/
https://www.ncbi.nlm.nih.gov/pubmed/23555926
http://dx.doi.org/10.1371/journal.pone.0060206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608603/
https://www.ncbi.nlm.nih.gov/pubmed/23555926
http://dx.doi.org/10.1371/journal.pone.0060206

Ejemplares similares